Community Calendar

Event questions?

Click here to email your question.

Overpromised Cures

Bookmark and Share

Title

Overpromised Cures

Location

University of California, Riverside

Start Date/Time

5/25/2017 11:30 AM

End Date/Time

5/25/2017 1:00 PM

Type of Event

Conferences Workshops and Seminars

Contact

shayna.conaway@ucr.edu, ucr-kaplan.eventbrite.com

Description

"Overpromised Cures: Why We Need to Rethink Investments in Medical Care and Biomedical Research" |  | Robert M. Kaplan | Distinguished Fellow, Purdue University; Professor of Medicine, Stanford University; Director of Research, Stanford Clinical Excellence Research Center (CERC) |  | RSVP via ucr-kaplan.eventbrite.com or https://www.eventbrite.com/e/overpromised-cures-why-we-need-to-rethink-investments-in-medical-care-and-biomedical-research-registration-33832283270 |  | Co-hosted by: | UCR School of Public Policy | UCR School of Medicine | One Health Center |  | Event information: |  | Directions to UCR: https://www.ucr.edu/about/directions.html |  | Location of venue: http://campusmap.ucr.edu/?loc=INTS |  | Parking is not free for this event. Attendees must purchase a parking permit via a permit dispenser in Lot 24 (not the parking kiosk/information desk): http://campusmap.ucr.edu/?loc=Lot24  |  | We can make reasonable accommodations for those with special needs if informed at least two weeks ahead of the event date. |  | BIO: | Robert M. Kaplan has served as Chief Science Officer at the US Agency for Health Care Research and Quality (AHRQ) and Associate Director of the National Institutes of Health, where he led the behavioral and social sciences programs.  He is also a Distinguished Emeritus Professor of Health Services and Medicine at UCLA, where he led the UCLA/RAND AHRQ health services training program and the UCLA/RAND CDC Prevention Research Center. He was Chair of the Department of Health Services from 2004 to 2009.  From 1997 to 2004 he was Professor and Chair of the Department of Family and Preventive Medicine, at the University of California, San Diego. He is a past President of several organizations, including the American Psychological Association Division of Health Psychology, Section J of the American Association for the Advancement of Science (Pacific), the International Society for Quality of Life Research, the Society for Behavioral Medicine, and the Academy of Behavioral Medicine Research. Kaplan is a former Editor-in-Chief of Health Psychology and of the Annals of Behavioral Medicine.  His 20 books and over 500 articles or chapters have been cited more than 30,000 times (H-index>90) and the ISI includes him in the listing of the most cited authors in his field (defined as above the 99.5th percentile). Kaplan is an elected member of the National Academy of Medicine (formerly the Institute of Medicine).  He is currently Regenstrief Distinguished Fellow at Purdue University and Professor of Medicine at Stanford University, where he servers as Director of Research at Stanford’s Clinical Excellence Research Center (CERC).  He holds MA and PhD degrees from UCR. |  | ABSTRACT: | Healthcare in the United States is the biggest sector in the largest economy in the history of the world. This year, we will spend nearly $3.2 trillion on health services. In addition, the United States has the largest biomedical research enterprise in the world with annual federal expenditures approaching $35 billion. Despite these large expenditures, health outcomes in the United States are not exceptional. In contrast to other prosperous economies, life expectancies in the United States have been systematically losing ground over the last 35 years.This presentation uses a variety of data sources to challenge  the narrative that the investments on medical research and medical care are on the right track. The presentation offers detailed analyses of progress in basic biological science, including precision medicine.  It summarizes evidence from the current literature and concludes that we need a shake-up in the dominant paradigm. The analyses also suggest that many public health services may have been under resourced. Both public health and traditional biological models require continuing support. However, the allocation models may need adjustment.  A new allocation model might ultimately lead to better  health for more people without increasing cost. |  | Cost: Free

Map of Event